Baraliakos, X., Braun, J., Deodhar, A., Poddubnyy, D., Kivitz, A., Tahir, H., . . . Fierlinger, A. (2019). Long-term efficacy and safety of secukinumab 150 mg in ankylosing spondylitis: 5-year results from the phase III MEASURE 1 extension study. RMD Open.
Citação norma ChicagoBaraliakos, Xenofon, et al. "Long-term Efficacy and Safety of Secukinumab 150 Mg in Ankylosing Spondylitis: 5-year Results From the Phase III MEASURE 1 Extension Study." RMD Open 2019.
Citação norma MLABaraliakos, Xenofon, et al. "Long-term Efficacy and Safety of Secukinumab 150 Mg in Ankylosing Spondylitis: 5-year Results From the Phase III MEASURE 1 Extension Study." RMD Open 2019.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.